Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GILEAD SCIENCES, INC. Director's Dealing 2019

Apr 25, 2019

29828_dirs_2019-04-25_95a746cd-4bf0-48a8-867c-1c32dae42df7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-04-24

Reporting Person: Lofton Kevin E (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-04-24 Common Stock M 13208 $24.905 Acquired 43332 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-04-24 Non-qualified Stock Option (Right to Buy) $24.905 M 13208 Disposed 2019-07-29 Common Stock (13208) Direct

Footnotes

F1: The options vested quarterly over the first year of service and were fully vested on July 29, 2010.